Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Wednesday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Alliance Global Partners initiated coverage on Lipocine in a report on Tuesday, September 24th. They issued a “buy” rating and a $10.00 target price for […]
4 Jan 06:46 · The Markets Daily